The MASCC Textbook of Cancer Supportive Care and Survivorship

Addressing physical and psychosocial matters of survivorship prior to, during, and after anticancer treatment is central to a patient’s wellbeing. The MASCC Textbook of Cancer Supportive Care and Survivorship explores not only the diagnosis and treatment but also the increasingly recognized complex and ongoing symptoms experienced by long term cancer survivors. Significant advances have been made, designing strategies to manage the side effects and symptoms of treatment and to prevent them from occurring, maximizing the person’s ability to pursue daily activities.

The MASCC Textbook of Cancer Supportive Care and Survivorship assembles international, multidisciplinary experts who focus on a comprehensive range of symptoms and side effects associated with cancer and its treatment. Intended for health professionals involved with cancer care, medical oncologists, radiation oncologists, surgeons, general practitioners, nurses and allied health workers, this textbook provides current information on the management and prevention of cancer related side effects, referring to up-to-date sources that are useful for conducting further research.

From the reviews:

“This book reviews the management of cancer symptoms in patients and the side effects and late effects of treatment. The focus of the book is on supportive care and survivorship of cancer patients. The intended audience encompasses any healthcare professional who manages patients with cancer. The book covers symptomatology, medication and treatment, and system function of patients undergoing chemotherapy or radiation therapy. … Photographs and algorithm charts further illustrate key points. This outstanding book is thorough in its explanations and easy to follow.” (Arlenda C. Thompson, Doody’s Review Service, January, 2011)

Ian Olver graduated from the University of Melbourne in 1976 being subsequently awarded an MD in 1991 for a project on clinical trial methodology. He is a Fellow of the Royal Australasian College of Physicians (FRACP), its Chapter of Palliative Medicine (FAChPM) and is a member of the Royal Australian College of Medical Administrators (MRACMA). He completed a PhD from Monash University in bioethics in 1997 (supervised by Peter Singer), exploring life and death issues and a Certificate of Ministry (Lay Preaching) at the Adelaide College of Divinity. He initially trained in medical oncology at Peter MacCallum Cancer Institute, the Alfred Hospital in Melbourne and the University of Maryland Cancer Centre in Baltimore. He worked for 6 years at the Peter MacCallum Cancer Institute where he jointly developed the oncology clinic at Bendigo Base Hospital and then moved to Adelaide becoming the Clinical Director, Royal Adelaide Hospital Cancer Centre and the first Cancer Council SA Professor of Cancer Care at the University of Adelaide and is currently an Adjunct Professor in the Department of Medicine. There he established the first oncology clinic in Alice Springs and developed a telemedicine link for multidisciplinary cancer care between Adelaide and Darwin. He also trained the first oncologist for the Christian Medical College Hospital Vellore, India. In May 2006 he was appointed CEO, Cancer Council Australia, a Clinical Professor in the Department of Medicine at the University of Sydney and is an Honorary Associate, Department of Medical Oncology, Royal Prince Alfred Hospital. He has published over 180 articles in journals, 16 book chapters and 2 books: Conquering Cancer. Your Guide to Treatment and Research, and Is Death Ever Preferable to Life? and co-edited When Cancer Crosses Disciplines: A Physicians Handbook. After serving on several ethics committees in Victoria and South Australia and the American Society of Clinical Oncology (ASCO) Ethics Committee, and chairing the Cancer Institute NSW Research Ethics Committee for multi-centre cancer trials, he now sits on the Australian Health Ethics Committee of the NHMRC and chairs the Medical Oncology Group of Australia Ethics Committee. He previously served on The Australian Drug Evaluation Committee (ADEC) and the Cancer Strategies Group of the Australian Government and chaired the Medical Oncology Group of Australia (MOGA). He now serves on the Board of the National Breast and Ovarian Cancer Centre, the executive of the Clinical Oncological Society of Australia and the Advisory Board of Cancer Australia and the Community and Preventative Health Committee of NH+MRC. In 2008 he was awarded the Cancer Achievement Award by MOGA.